article This week’s edition of The Wall St. Journal features the latest research on the impact of the use of Covid-19 vaccines and other vaccines on the development of new infections and the development and transmission of new infectious diseases.
The paper is by a team of researchers led by David S. Nadel, a professor of epidemiology and biostatistics at the University of California, San Francisco.
Nada, the first-ever study of the effect of CovID-19 vaccination on the risk of developing a new disease, was published in the journal Science.
A new paper on the same topic by Nadel and his team, published in September, found that the Covid vaccine was significantly protective against the development, spread and acquisition of a new coronavirus.
“Our work is the first to show that Covid is the single most important determinant of whether people are able to acquire new coronavia infections, and our findings suggest that there may be benefits to a large-scale use of a Covids vaccine for preventing new coronovirus infections,” Nadel said.
The new research was funded by the National Institutes of Health, the Bill and Melinda Gates Foundation and the Bill & Melinda Gore Foundation.